{"id":"W3128131226","doi":"10.1038/s41571-021-00473-5","title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1560,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biomarker; Concordance; Biomarker discovery; Oncology; Companion diagnostic; Immune checkpoint; Clinical trial; PD-L1; Cancer; Disease; Internal medicine; Immunotherapy; Bioinformatics; Biology; Proteomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}